Inbox Robot: Biopharmaceuticals News http://www.inboxrobot.com/news/biopharmaceuticalsConstantly updated news and information about a variety of topics. FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas http://www.inboxrobot.com/news.php?fid=177739790 9 Jul 2008 10:35 GMT ... additional regulatory support for ongoing R&D initiatives. Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of ... Daniel B. Dubin, M.D., Joins NanoBio Corp.'s Board of Directors http://www.inboxrobot.com/news.php?fid=177736263 9 Jul 2008 09:56 GMT ... Jul. 08, 2008 ANN ARBOR, Mich., July 08, 2008 /PRNewswire/ -- NanoBio(R) Corp., a biopharmaceutical company focused on developing and commercializing novel products to prevent and treat infectious diseases, ... --> DIREVO announces transfer of patents from Evotec http://www.inboxrobot.com/news.php?fid=177734438 9 Jul 2008 09:38 GMT ... is committed to a tailored approach to addressing customer needs and market opportunities. DIREVO's biopharmaceutical business generates improved second generation therapeutics and discovers and optimizes novel first-generation therapeutics. DIREVO ... DIREVO announces transfer of patents from Evotec http://www.inboxrobot.com/news.php?fid=177732535 9 Jul 2008 09:32 GMT ... is committed to a tailored approach to addressing customer needs and market opportunities. DIREVO's biopharmaceutical business generates improved second generation therapeutics and discovers and optimizes novel first-generation therapeutics. DIREVO ... ViroPharma Provides Update On Upcoming FDA Advisory Committee Meeting To Discuss Bioequivalence Of Locally Acting Gastrointestinal Drugs http://www.inboxrobot.com/news.php?fid=177731066 9 Jul 2008 09:30 GMT ... megacolon, peritonitis and perforation of the colon. About ViroPharma Incorporated ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated ... Emisphere Announces Data From Independent Clinical Study Of Effects Of Oral GLP-1 On Glucose And Insulin Concentrations http://www.inboxrobot.com/news.php?fid=177731062 9 Jul 2008 09:30 GMT ... Nordisk's proprietary GLP-1 receptor agonists. ABOUT EMISPHERE TECHNOLOGIES, INC. Emisphere Technologies, Inc. is a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical ... Epeius Biotechnologies' Tumor Targeted Rexin G Receives FDA Orphan Drug Designation For The Treatment Of Osteosarcoma http://www.inboxrobot.com/news.php?fid=177731059 9 Jul 2008 09:30 GMT ... of Rexin-G for osteosarcoma. About Epeius Biotechnologies Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of ... Regulatory news: PAION AG: Publication of announcement acc. to 30e WpHG http://www.inboxrobot.com/news.php?fid=177724503 9 Jul 2008 08:24 GMT ... to start first-in-man study Aachen (Germany), Cambridge (United Kingdom), 9 July 2008 - The biopharmaceutical company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange, Prime Standard: PA8, London AIM: PAI.L) ... RegeneRx Completes Dosing in Phase I Safety Trial http://www.inboxrobot.com/news.php?fid=177689822 9 Jul 2008 04:25 GMT ... | Vol. 6 No. 28 RegeneRx Completes Dosing in Phase I Safety Trial RegeneRx Biopharmaceuticals has completed enrollment and dosing for its Phase Ia clinical trial testing RGN-352 for ... National Venture Capital Association and Dow Jones VentureWire Release Results of Venture Census 2008 http://www.inboxrobot.com/news.php?fid=177679915 9 Jul 2008 02:08 GMT ... less, 77 percent were male; 23 percent female. Women were most prevalent in the biopharmaceuticals sector where 32 percent of the respondents were female and least prevalent in the ... FDA Grants Epeius Biotechnologies' Rexin-G A Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue S http://www.inboxrobot.com/news.php?fid=177661696 8 Jul 2008 22:57 GMT ... for ongoing R&D initiatives. About Epeius Biotechnologies Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of ... Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatmen http://www.inboxrobot.com/news.php?fid=177647033 8 Jul 2008 21:12 GMT ... the clinical development of Rexin-G for osteosarcoma. Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of ... FFF Enterprises Celebrates 20 Counterfeit-Free Years http://www.inboxrobot.com/news.php?fid=177645941 8 Jul 2008 20:51 GMT ... in short supply. That was 1988, when qualifying as a distributor of critical care biopharmaceuticals was relatively easy, with minimal requirements and almost no regulation. My initial intention was ... Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for The Treatment of Osteosarcoma http://www.inboxrobot.com/news.php?fid=177642277 8 Jul 2008 20:30 GMT ... the clinical development of Rexin-G for osteosarcoma. Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of ... Gilead Sciences to Release Second Quarter 2008 Financial Results on Thursday, July 17, 2008 http://www.inboxrobot.com/news.php?fid=177641424 8 Jul 2008 20:25 GMT ... the participant passcode 84267247. The webcast will be archived on Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. ...